Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Carlos Benitez

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Translational Lung Cancer Research|July 23, 2021
Narrative review of immunotherapy in thymic malignanciesJose Carlos Benitez, Benjamin Besse
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2020
Current Panorama and Challenges for Neoadjuvant Cancer ImmunotherapyJose Carlos Benitez, Jordi Remon, Benjamin Besse
Expert Opinion on Pharmacotherapy|February 17, 2021
An overview of osimertinib as a treatment of non-small cell lung cancer (NSCLC): an updateLuigi Cerbone, Jose Carlos Benitez, David Planchard, et al.
Cancer Discovery|November 2, 2021
New Immunotherapy Combinations Enter the Battlefield of Malignant MesotheliomaMihaela Aldea, Jose Carlos Benitez, Nathalie Chaput, et al.
Cancers|July 12, 2025
Emerging Techniques of Translational Research in Immuno-Oncology: A Focus on Non-Small Cell Lung CancerMora Guardamagna, Eduardo Zamorano, Victor Albarrán-Artahona, et al.
The Lancet. Oncology|September 30, 2021
Late phase 1 studies: concepts and outcomesJose Carlos Benitez, Arthur Geraud, Matthieu Texier, et al.
Journal of Personalized Medicine|June 2, 2021
Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal CancerJose Carlos Benitez, Marc Campayo, Tania Díaz, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2021
Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie studyNicolas Epaillard, Jose Carlos Benitez, Teresa Gorria, et al.
JCO Global Oncology|March 21, 2024
Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data StudyNuria Ribelles, Javier Pascual, Laura Galvez-Carvajal, et al.
Virchows Archiv : an International Journal of Pathology|February 25, 2021
Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC studyVincent Thomas de Montpreville, Audrey Mansuet-Lupo, Cécile Le Naoures, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Translational Lung Cancer Research|July 23, 2021
Narrative review of immunotherapy in thymic malignanciesJose Carlos Benitez, Benjamin Besse
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2020
Current Panorama and Challenges for Neoadjuvant Cancer ImmunotherapyJose Carlos Benitez, Jordi Remon, Benjamin Besse
Expert Opinion on Pharmacotherapy|February 17, 2021
An overview of osimertinib as a treatment of non-small cell lung cancer (NSCLC): an updateLuigi Cerbone, Jose Carlos Benitez, David Planchard, et al.
Cancer Discovery|November 2, 2021
New Immunotherapy Combinations Enter the Battlefield of Malignant MesotheliomaMihaela Aldea, Jose Carlos Benitez, Nathalie Chaput, et al.
Cancers|July 12, 2025
Emerging Techniques of Translational Research in Immuno-Oncology: A Focus on Non-Small Cell Lung CancerMora Guardamagna, Eduardo Zamorano, Victor Albarrán-Artahona, et al.
The Lancet. Oncology|September 30, 2021
Late phase 1 studies: concepts and outcomesJose Carlos Benitez, Arthur Geraud, Matthieu Texier, et al.
Journal of Personalized Medicine|June 2, 2021
Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal CancerJose Carlos Benitez, Marc Campayo, Tania Díaz, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2021
Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie studyNicolas Epaillard, Jose Carlos Benitez, Teresa Gorria, et al.
JCO Global Oncology|March 21, 2024
Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data StudyNuria Ribelles, Javier Pascual, Laura Galvez-Carvajal, et al.
Virchows Archiv : an International Journal of Pathology|February 25, 2021
Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC studyVincent Thomas de Montpreville, Audrey Mansuet-Lupo, Cécile Le Naoures, et al.
Pageof 2